Bone-destruction-associated diseases are mediated by the immune system.
Osteoclasts, the bone resorbing cells, act upon the influence of inflammatory mediators.
Dendritic cells have been highlighted as crucial osteoclast providers upon inflammatory conditions.
Understanding the role of dendritic-cell-derived osteoclasts in bone inflammatory diseases could lead to therapeutic strategies.